On 26 February, the AMYPAD initiative released its fourth external newsletter and reported what has been achieved during the first year of the project. The team was proud to look back at a lot of successful deliveries.
This project has received funding from the Innovative Medicines Initiative 2 Joint undertaking under grant agreement No 115952. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.